We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNB icon
1651
FNB Corp
FNB
$6.75B
$29K ﹤0.01%
2,986
-34,717
-92% -$403K
FNF icon
1652
Fidelity National Financial
FNF
$13.5B
$29K ﹤0.01%
+951
New +$30.7K
KE
1653
Kimball Electronics
KE
$628M
$29K ﹤0.01%
+1,909
New +$33.6K
MORN icon
1654
Morningstar
MORN
$7.53B
$29K ﹤0.01%
265
-932
-78% -$109K
MRAM icon
1655
Everspin Technologies
MRAM
$405M
$29K ﹤0.01%
+5,249
New +$35.9K
ORA icon
1656
Ormat Technologies
ORA
$6.65B
$29K ﹤0.01%
+560
New +$29.5K
RMCF icon
1657
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$29K ﹤0.01%
3,439
+922
+37% +$8.05K
THRM icon
1658
Gentherm
THRM
$1.27B
$29K ﹤0.01%
+715
New +$30.3K
VLRS
1659
Controladora Vuela Compania de Aviacion
VLRS
$939M
$29K ﹤0.01%
5,340
+4,190
+364% +$26.6K
WAB icon
1660
Wabtec
WAB
$49.3B
$29K ﹤0.01%
425
-11,166
-96% -$974K
PACW
1661
DELISTED
PacWest Bancorp
PACW
$29K ﹤0.01%
892
-16,454
-95% -$656K
XLNX
1662
DELISTED
Xilinx Inc
XLNX
$29K ﹤0.01%
344
-3,107
-90% -$260K
ALXN
1663
DELISTED
Alexion Pharmaceuticals
ALXN
$29K ﹤0.01%
+299
New +$35.3K
GMLP
1664
DELISTED
Golar LNG Partners LP
GMLP
$29K ﹤0.01%
2,680
+2,539
+1,801% +$33.4K
AFH
1665
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$29K ﹤0.01%
3,503
-3,948
-53% -$37.7K
WEBK
1666
DELISTED
Wellesley Bancorp, Inc.
WEBK
$29K ﹤0.01%
1,032
+372
+56% +$11.6K
SNNA
1667
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$29K ﹤0.01%
12,183
+10,545
+644% +$93K
BILI icon
1668
Bilibili
BILI
$7.84B
$28K ﹤0.01%
+1,935
New +$27.1K
DHT icon
1669
DHT Holdings
DHT
$3.02B
$28K ﹤0.01%
6,946
+5,046
+266% +$23.4K
EMLC icon
1670
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.84B
$28K ﹤0.01%
+838
New +$27.4K
FBNC icon
1671
First Bancorp
FBNC
$2.68B
$28K ﹤0.01%
+856
New +$32K
FC icon
1672
Franklin Covey
FC
$246M
$28K ﹤0.01%
1,269
+637
+101% +$14.2K
HBCP icon
1673
Home Bancorp
HBCP
$566M
$28K ﹤0.01%
804
+443
+123% +$17.1K
KBR icon
1674
KBR
KBR
$4.8B
$28K ﹤0.01%
1,836
-10,985
-86% -$205K
MC icon
1675
Moelis & Co
MC
$4.94B
$28K ﹤0.01%
823
+539
+190% +$22.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.